PredOmix Health

31/12/2024

As we welcome the New Year at PredOmix, we reflect on 2024 with gratitude and renewed determination! This past year has been an extraordinary journey filled with growth and achievements, bringing us closer to our mission of transforming early cancer detection. Our progress is a testament to our dedicated team, supportive partners, and the trust of our collaborators.

We extend heartfelt appreciation to our Scientific Advisory Board Members and Investors for their invaluable guidance and unwavering faith in our vision. Together, we’ve made significant strides in improving lives through early cancer detection.

Here are some highlights from our 2024 journey:

Expanding Cancer Detection: We’ve scaled our technology from screening 4 cancers in women to detecting 30 cancers in both men and women, underscoring its vital role in saving lives.

Building Partnerships: We forged impactful collaborations with partners across India, enhancing the reach of our innovative cancer screening solutions.

Advancing Clinical Trials: Our successful registration of clinical trials for OncoVeryx is set to conclude in January 2025, positioning us for an early market launch.

Clinician Trust: Our commitment to quality has led to high satisfaction rates among clinicians, reinforcing our mission to transform early cancer care.

Strengthening Our Team: From a small group of passionate individuals, we’ve grown into a diverse team united by a shared goal to reshape cancer detection.

As we step into 2025, we are excited about the possibilities ahead. Our journey is just beginning, and we are dedicated to making a lasting impact in early cancer detection.

Here’s to a year of learning, growth, and making a difference together!

Happy New Year from everyone at PredOmix!

24/12/2024

🎄✨ Merry Christmas from the PredOmix Family! ✨🎄

As we celebrate the season of joy and togetherness, we are grateful for your continued support and trust in our journey.

May your holiday season be filled with warmth, laughter, and good health. Here's to a brighter, healthier future in 2025 and beyond!

🎁 Stay safe, cherish your loved ones, and spread kindness this festive season.

🌟 Merry Christmas and Happy New Year! 🌟

22/11/2024

Latest Publication: Development of a Serum Metabolome-Based Test for Early-Stage Detection of Multiple Cancers
https://lnkd.in/gb8fYKpF

We are thrilled to share that our latest publication in Cancer Reports highlights the success of our serum metabolome-based test for early-stage detection of 30 cancers with an outstanding accuracy of ~98%.

This cutting-edge blood test, developed by PredOmix, uses machine learning and metabolomics to identify multiple cancers in both men and women, offering a significant advancement in the fight against cancer.

Key Findings from Our Publication:
-The test successfully detects 30 types of cancers in both males and females.
-Achieves ~98% accuracy across all cancer stages, even in the early stages (Stage I and II).
-Utilizes advanced machine learning and high-resolution mass spectrometry to differentiate cancer from non-cancer samples.

Why This Matters:
This publication further demonstrates the effectiveness of our test, reinforcing its potential to transform cancer detection, offering a non-invasive, highly accurate, and accessible solution to detect cancer at its earliest stages.

A Special Thanks to Our Collaborators:
We would like to extend our heartfelt gratitude to our collaborators and coauthors who played a crucial role in this project. Their expertise and dedication have been instrumental in the success of this work.

Access the full publication and learn more about our revolutionary test: [https://lnkd.in/gb8fYKpF

30/10/2024

01/10/2024

Metabolomics Meets AI: Dr. Ankur Gupta's at MIST, Turku!

We are pleased to share that Dr. Ankur Gupta, Head of AI at PredOmix, was invited as a guest speaker for the MIST Research Program at Turku! It was a true privilege to have him present his insights on an integrated metabolomics-based platform for the early-stage detection of multiple cancers.

The seminar was hosted by Professor Riitta Lahesmaa and organized by the MIST Research Program, BioCity Turku, and Turku Bioscience Centre.

Dr. Gupta’s expertise opened up engaging discussions on the potential of advanced technologies in transforming early detection methodologies. We extend our heartfelt thanks to Dr. Gupta for sharing his valuable knowledge and to all attendees for contributing to a lively exchange of ideas!

Together, let’s continue pushing the boundaries of cancer research and early detection!

17/09/2024

🎗️ What Women May Not Know About Ovarian Cancer 🎗️
Ovarian cancer is often called a "silent killer" because the symptoms can be subtle and easy to miss. Here are a few things that every woman should be aware of:
Silent Symptoms: Bloating, abdominal pain, or feeling full quickly could be early signs.
Family History: A history of breast or ovarian cancer increases your risk.
It’s Not Just for Older Women: It can happen in your 30s and 40s too.
No Routine Screening: Pap smears don’t detect it. Be aware of your body.
Birth Control Lowers Risk: Long-term use of the pill can reduce your chances.
Early Detection Saves Lives: If caught early, survival rates are much higher.
It Can Recur: Regular check-ups are crucial after treatment.
Let’s raise awareness and talk more openly about ovarian cancer 💪💚

17/09/2024

What an inspiring experience at in beautiful Barcelona! Grateful for the connections made and the insights gained. Can’t wait for the next one! 🌍✨ "🇪🇸

13/09/2024

Hello from Day 1 at ESMO Barcelona! 🎉 Excited to talk about multi-cancer early detection? Come say hi and connect with us here! Let's explore how we can make early detection a reality together. You can find us at the poster area. # Team PredOmix

15/08/2024

Happy Independence Day, India! 🇮🇳
As we celebrate our nation’s freedom, let’s also commit to the freedom of living healthier and happier lives.
This Independence Day, let's pledge to take care of our well-being, and create a brighter, stronger, healthier nation.

21/05/2024

🧠 Go Gray in May: Brain Cancer Awareness Month.
May is Brain Cancer Awareness Month, a time to honor those affected by brain cancer and to amplify the importance of early detection. Early diagnosis can significantly improve treatment outcomes and survival rates, making awareness and innovation in detection methods more crucial than ever.
This is where innovations like OncoVeryx can make a significant impact. OncoVeryx is a groundbreaking test to detect brain cancer at its earliest stages through a simple blood test. Early-stage detection is pivotal because it often means the cancer is still localized and more likely to be treatable and curable.
Here's why early detection is so critical:
Better Prognosis: Early detection can lead to earlier intervention, increasing the chances of successful treatment.
Less Aggressive Treatment: When caught early, treatment can often be less invasive and less aggressive, reducing side effects and improving the quality of life for patients.
Increased Survival Rates: The earlier brain cancer is detected, the higher the survival rates. Early-stage cancers have a significantly better prognosis compared to advanced stages.
OncoVeryx's innovative blood test represents a major step forward in the fight against brain cancer. By making early detection more accessible and less invasive, we have a better chance to save lives and improve outcomes for countless individuals.
Let's support the fight against brain cancer by spreading awareness about the importance of early detection and the innovative solutions making a difference. Wear gray, share this message, and encourage those around you to get informed about brain cancer and the advancements in early detection.
Visit www.predomix.com for more information.

08/05/2024

8th of May signals World Ovarian Cancer Day!
At PredOmix, we are raising awareness to fight this silent killer.

Unfortunately, there is presently no dependable screening test available for ovarian cancer. Neither PAP smears nor pelvic exams prove effective in early detection of the disease. The primary screening method, a blood test known as CA-125, lacks specificity for ovarian cancer and can yield false-positive outcomes. If you're at higher risk, like with a family history, regular pelvic exams & ultrasounds could help. OncoVeryx-F, developed by PredOmix, offers promise as a simple blood test with higher accuracy for cancer detection than other available methods, especially for high-risk women. It's crucial to engage in a conversation with your doctor regarding your individual risk factors to devise the most suitable screening strategy for you.Know the symptoms and empower yourself by getting checked. Together, we can make a difference!
Book Your OncoVeryx-F Test Now!
www.predomix,com

08/04/2024

India now declared as the 'Cancer Capital of the World'!!

It's concerning to hear that India has been named the "Cancer Capital of the World" in a recent report released by Apollo Hospitals. This tells us that we need to act fast to tackle this serious issue.
Here are some proactive steps we think that are crucial in the fight against cancer.
1. Promote Prevention: Empower individuals with knowledge about healthy lifestyle choices, including balanced nutrition, regular exercise, and to***co cessation.
2. Expand Access to Screening: Early Detection Saves Lives!! Increase access to affordable and widespread cancer screening programs, particularly in rural and underserved areas, to facilitate early detection and intervention.
3. Strengthen Healthcare Infrastructure: Invest in healthcare infrastructure and workforce development to ensure equitable access to cancer diagnosis, treatment, and supportive care services across the country.
4. Raise Awareness and Education: Launch comprehensive public health campaigns to raise awareness about cancer prevention, symptoms, and available resources, addressing stigma and misconceptions surrounding the disease.
5. Foster Research and Innovation: Support research collaborations and innovation in cancer prevention, diagnosis, and treatment, with a focus on addressing the specific needs and challenges of the Indian population.

Together, we can work towards a future where no individual or family has to face the devastating impact of cancer. Let's unite our efforts to make India a beacon of hope in the global fight against this disease. 🌟